课题基金 / 基金详情

REGULATION OF TGF-β AND ITS SIGNAL MOLECULE, SMAD, FOR ATTENUATION OF GLOEMRULAR DISEASE.

REGULATION OF TGF-β AND ITS SIGNAL MOLECULE, SMAD, FOR ATTENUATION OF GLOEMRULAR DISEASE.
调节 TGF-β 及其信号分子 SMAD,以减轻肾小球疾病。
批准号:
11671063
负责人:
TAMAKI Kiyoshi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TAMAKI Kiyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
TGF-β1在包括肾小球硬化和肾纤维化的纤维化疾病中起病理作用。Smads已被确定为TGF-β细胞内信号传导的关键成分。本研究探讨了TGF-β1对大鼠系膜细胞Smad活性的影响。在系膜细胞中,TGF-β1而不是BMP-7诱导Smad 2磷酸化。相反,BMP-7,而不是TGF-β1,诱导BMP相关Smads的磷酸化。TGF-β1以剂量和时间依赖的方式刺激Smad 2的磷酸化。腺病毒介导的基因转移、Smad 2和Smad 4的双重过表达诱导了TGF-β1刺激的纤溶酶原激活物抑制剂-1(派-1)的表达。Smad 7(Smad 6)的过表达可阻断TGF-β1诱导的派-1表达,并通过抑制Smad 2磷酸化逆转TGF-β1抑制的细胞增殖。在使用Thy-1肾炎的实验性肾小球肾炎中,Smad 2磷酸化以与肾小球基质扩张相似的方式瞬时显著增加。在受损的肾小球中观察到磷酸化的Smad 2。这些结果提示,Smad蛋白在体内外肾小球系膜细胞中均存在,并作为TGF-β的信号分子发挥作用。我们的研究结果表明,Smad活性的调节可能会减弱肾小球硬化和纤维化的发展
英文摘要
TGF-β1 plays a pathological role in fibrotic diseases including glomerulosclerosis and renal fibrosis. Smads have been identified as pivotal components in TGF-β intracellular signaling. The present study was carried out to investigate TGF-β1-induced Smad activation in cultured mesangial cells and experimental mesangioproliferative glomerulonephritis in rats. In mesangial cells, TGF-β1, but not BMP-7, induced phosphorylation of Smad2. In contrast, BMP-7, but not TGF-β1, induced phosphorylation of BMP-related Smads. TGF-β1 stimulated the phosphorylation of Smad2 in a dose- and time-dependent manner. Gene transfer using Adenovirus-vector, double-overexpression of Smad2 and Smad4 induced TGF-β1-stimulated plasminogen activator inhibitor-1 (PAI-1) expression more than overexpression of each Smad alone. Furthermore, overexpression of Smad7, one of inhibitory Smads, but not Smd6, blocked TGF-β1-induced PAI-1 expression and reversed TGF-β1-inhibited cell proliferation by inhibiting Smad2 phosphorylation. In experimental glomerulonephritis using Thy-1 nephritis, Smad2 phosphorylation increased transiently and significantly in a similar manner to glomerular matrix expansion. Phosphorylated Smad2 was observed in the damaged glomeruli. These results suggested that Smad proteins are present and act as signaling molecule of TGF-β in mesangial cells in vitro and in vivo. Our results indicate the possibility that modulation of Smad activity may attenuate the development of glomerulosclerosis and fibrosis
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Kashiwagi M,Tamaki K et al: "Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats."J Am Soc Nephrology. 11. 616-624. (2000)
Kashiwagi M、Tamaki K 等人:“局部激活的肾素-血管紧张素系统与 TGF-β1 相关,是大鼠慢性抑制一氧化氮合酶诱导肾损伤的主要因素。”J Am Soc Nephrology。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishisaki A,Tamaki, et al: "Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells"J Biol Chem. 274. 13637-13642 (1999)
Ishisaki A、Tamaki 等人:“Smad6 和 Smad7 对 B 细胞中骨形态发生蛋白和激活素介导的生长停滞和凋亡的差异抑制”J Biol Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamai O, Tamaki K,, Okuda S et al: "Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis."Kidney Int.. 59. 471-480 (2001)
Tamai O、Tamaki K、Okuda S 等人:“系膜细胞中的小窝和小窝蛋白在系膜增殖性肾小球肾炎中的表达。”Kidney Int.. 59. 471-480 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamaki K: "Transforming Growth Factor(TGF)-β1 Induced Phosphorylation of Smad2 in Mesangial Cells In Vitro and In Vivo."J Am Soc Nephrol. 10巻. 581 (1999)
Tamaki K:“转化生长因子 (TGF)-β1 在体外和体内诱导系膜细胞磷酸化。J Am Soc Nephrol。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 13 条
    Proteomic approach to protein involving diabetic nephropathy
    • 批准号:
      15590870
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      TAMAKI Kiyoshi
    • 依托单位:
    REGULATION OF PROMER OF TGF-β/SMAD-TARGET GENE FOR ATTENUATION OF RENAL FIBROSIS
    • 批准号:
      13671132
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      TAMAKI Kiyoshi
    • 依托单位:
    国内基金
    海外基金
    新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
    LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
    • 批准号:
      2026JJ82108
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谭亮
    • 依托单位:
    基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究
    黄精多糖通过TGF-β/SMAD信号通路抑制成纤维细胞活化治疗肺纤维化的机制研究与转化探索
    • 批准号:
      JCZRLH202602010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: